INTRACRANIAL MENINGIOMA
Clinical trials for INTRACRANIAL MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new INTRACRANIAL MENINGIOMA trials appear
Sign up with your email to follow new studies for INTRACRANIAL MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain tumor patients: targeted drugs aim to halt meningioma growth
Disease control Recruiting nowThis study tests four targeted drugs (vismodegib, GSK2256098, capivasertib, and abemaciclib) in people with progressive meningiomas that have specific gene mutations. The goal is to see if these drugs can stop or slow tumor growth. About 124 adults with recurrent or worsening men…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Brain tumor study: is radiation after surgery worth it?
Disease control Recruiting nowThis study looks at whether giving radiation therapy after complete removal of a grade II meningioma (a type of brain tumor) helps keep the tumor from coming back, compared to just watching and waiting. About 163 people with newly diagnosed, fully removed tumors will be randomly …
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:52 UTC
-
New hope for brain tumor patients: targeted radiation trial launches
Disease control Recruiting nowThis study tests a drug called [177Lu]Lu-DOTATATE, which delivers radiation directly to meningioma tumor cells. It is for adults with progressive grade 1-3 meningioma that has worsened despite prior treatment. The goal is to see if this drug can slow tumor growth and improve surv…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC